|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2000-4-12
|
|
pubmed:abstractText |
Patients surviving ventricular fibrillation (VF) or sustained ventricular tachycardia (VT) are at a high risk of death due to a recurrence of arrhythmia. The implantable cardioverter defibrillator (ICD) terminates VT or VF, but it is not known whether this device prolongs life in these patients compared with medical therapy with amiodarone.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
21
|
|
pubmed:volume |
101
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1297-302
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10725290-Aged,
pubmed-meshheading:10725290-Amiodarone,
pubmed-meshheading:10725290-Anti-Arrhythmia Agents,
pubmed-meshheading:10725290-Defibrillators, Implantable,
pubmed-meshheading:10725290-Female,
pubmed-meshheading:10725290-Humans,
pubmed-meshheading:10725290-Male,
pubmed-meshheading:10725290-Middle Aged,
pubmed-meshheading:10725290-Proportional Hazards Models,
pubmed-meshheading:10725290-Risk Factors,
pubmed-meshheading:10725290-Tachycardia, Ventricular,
pubmed-meshheading:10725290-Ventricular Fibrillation
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
|
|
pubmed:affiliation |
Departments of Medicine, McMaster University, Hamilton, Ontario, Canada. connostu@hamcivhos.on.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
